ALBANY, NY (WRGB)- As state budget tensions continue, Medicaid patients and cancer advocates are raising concerns that access to biomarker testing could be narr ...

Biomarker testing is critical for determining optimal therapy early in the non–small lung cancer (NSCLC) treatment process, but research shows uneven insurance coverage of these tests and inconsistent ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Texas Oncology boosts precision medicine with near-universal biomarker testing, quality measurement, and genomic ...

An emerging category of laboratory tests may help improve care and treatment outcomes for cancer patients, according to a recent survey by the nonprofit CancerCare, but insurers and employers do not ...

When the U.S. COVID-19 public health emergency ends this month, coronavirus tests will still be available, but there will be changes to who pays for them. Questions remain about exactly what those ...